Is there an association between the use of anabolic-androgenic steroids and criminality?

European Addiction Research

Volumn 16, Issue 4, 2010, Pages 213-219

  Skrberg, Kurt ^a,b   Nyberg, Fred ^c   Engström, Ingemar ^a,d  

^a ÖREBRO UNIVERSITY   (Sweden)

^b Orebro County Council   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Psychiatric Research Centre   (Sweden)

Author keywords

Anabolic androgenic steroids; Crime; Drugs of abuse; Hormones; Steroids; Sweden; Violence

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

ADDICTION; ADULT; ARTICLE; ASSOCIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRIME; CRIMINAL BEHAVIOR; DRUG ABUSE; DRUG USE; FEMALE; HUMAN; INTERVIEW; MALE; MENTAL HOSPITAL; PRIORITY JOURNAL; SWEDEN; VIOLENCE; WEAPON;

ADULT; ANABOLIC AGENTS; BEHAVIOR, ADDICTIVE; CRIME; CRIMINALS; DATABASES, FACTUAL; HUMANS; MALE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SWEDEN; VIOLENCE;

EID: 77956089005     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320286     Document Type: Article

References (40)

1. Kuhn CM: Anabolic steroids. Recent Prog Horm Res 2002; 57: 411-434.
2. Evans NA: Gym and tonic: a profile of 100 male steroid users. Br J Sports Med 1997; 31: 54-58.
3. Nilsson S, Baigi A, Marklund B, Fridlund B: The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur J Public Health 2001; 11: 195-197.
4. Miller KE, Hoffman JH, Barnes GM, Sabo D, Melnick MJ, Farell MP: Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors. Subst Use Misuse 2005; 40: 1637-1657.
5. Gruber AJ, Pope HG Jr: Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000; 69: 19-26.
6. Ambrose PJ: Drug use in sports: a veritable arena for pharmacists. J Am Pharm Assoc 2004; 44: 501-514.
7. Middleman AB, Faulkner AH, Woods ER, Emans SJ, DuRant RH: High-risk behaviors among high school students in Massachusetts who use anabolic steroids. Pediatrics 1995; 96: 268-272.
8. Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F: The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol 2003; 59: 571-577.
9. Sjöqvist F, Garle M, Rane A: Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008; 371: 1872-1882.
10. Thiblin I, Lindquist O, Rajs J: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 2000; 45: 16-23.
11. Brower KJ, Blow FC, Beresford TP, Fuelling C: Anabolic-androgenic steroid dependence. J Clin Psychiatry 1989; 50: 31-33.
12. Skårberg K, Nyberg F, Engström I: Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res 2009; 15: 99-106.
13. Johansson-Steensland P, Nyberg F, Chahl L: The anabolic-androgenic steroid, nandrolone decanoate, increases the density of Foslike immunoreactive neurons in limbic regions of guinea-pig brain. Eur J Neurosci 2002; 15: 539-544.
14. Harrison RJ, Connor DF, Nowak C, Nash K, Melloni RH Jr: Chronic anabolic-androgenic steroid treatment during adolescence increases anterior hypothalamic vasopressin and aggression in intact hamsters. Psychoneuroendocrinology 2000; 25: 317-338.
15. Hall RC: Abuse of supraphysiologic doses of anabolic steroids. South Med J 2005; 98: 550-555.
16. Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS: Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry 2006; 21: 551-562.
17. Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS, Toli PN: Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins. Eur Psychiatry 2006; 21: 563-569.
18. Brower KJ: Anabolic steroid abuse and dependence. Curr Psychiatry Rep 2002; 4: 377-387.
19. Casavant MJ, Blake K, Griffith J, Yates A, Copley LM: Consequences of use of anabolic-androgenic steroids. Pediatr Clin North Am 2007; 54: 677-690.
20. Middleman AB, DuRant RH: Anabolic steroid use and associated health risk behaviours. Sports Med 1996; 21: 251-255.
21. Hall RC, Hall RC, Chapman MJ: Psychiatric complications of anabolic steroid abuse. Psychosomatics 2005; 46: 285-290.
22. Dabbs JM Jr, Frady RL, Carr TS, Besch NF: Saliva testosterone and criminal violence in young adult prison inmates. Psychosom Med 1987; 49: 174-182.
23. Brooks JH, Reddon JR: Serum testosterone in violent and nonviolent young offenders. J Clin Psychol 1996; 52: 475-483.
24. Beaver KM, Vaughn MG, Delisi M, Wright JP: Anabolic-androgenic steroid use and involvement in violent behavior in a nationally representative sample of young adult males in the United States. Am J Public Health 2008; 98: 2185-2187.
25. Choi PY, Pope HG Jr: Violence toward women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry 1994; 6: 21-25.
26. Thiblin I, Parlklo T: Anabolic androgenic steroids and violence. Acta Psychiatr Scand Suppl 2002; 412: 125-128.
27. Isacsson G, Garle M, Ljung EB, Asgård U, Bergman U: Anabolic steroids and violent crime: an epidemiological study at a jail in Stockholm, Sweden. Compr Psychiatry 1998; 39: 203-205.
28. Klötz F, Garle M, Granath F, Thiblin I: Criminality among individuals testing positive for the presence of anabolic-androgenic steroids. Arch Gen Psychiatry 2006; 63: 1274-1279.
29. Klötz F, Petersson A, Isacson D, Thiblin I: Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic-androgenic steroids and abusers of illicit drugs. Forensic Sci Int 2007; 173: 57-63.
30. Klötz F, Petersson A, Hoffman O, Thiblin I: The significance of anabolic androgenic steroids in a Swedish prison population. Compr Psychiatry 2010;51:312-318.
31. Pope HG Jr, Katz DL: Homicide and nearhomicide by anabolic steroid users. J Clin Psychiatry 1990; 51: 28-31.
32. Pope HG Jr, Kouri EM, Powell KF, Campbell C, Katz DL: Anabolic-androgenic steroid use among 133 prisoners. Compr Psychiatry 1996; 37: 322-327.
33. Petersson A, Garle M, Granath F, Thiblin I: Morbidity and mortality in patients testing positively for the presence of anabolic-androgenic steroids in connection with receiving medical care: a controlled retrospective cohort study. Drug Alcohol Depend 2006; 81: 215-220.
34. Andersson J: The Swedish National Council for Crime Prevention: a short presentation. J Scand Stud Criminol Crime Prev 2005; 6: 74-88.
35. Rubin H, Rubin I: Qualitative Interviewing. The Art of Hearing Data. Thousand Oaks, Sage, 2004.
36. Malone DA Jr, Dimeff RJ, Lombardo JA, Sample RH: Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med 1995; 5: 25-31.
37. Warren JI, South SC, Burnette ML, Rogers A, Friend R, Bale R, van Patten I: Understanding the risk factors for violence and criminality in women: the concurrent validity of the PCL-R and HCR-20. Int J Law Psychiatry 2005; 28: 269-289.
38. Degenhardt L, Day C, Hall W, Conroy E, Gilmour S: Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime? BMC Public Health 2005; 5: 40.
39. Messer LC, Kaufman JS, Dole N, Herring A, Laraia BA: Violent crime exposure classification and adverse birth outcomes: a geographically defined cohort study. Int J Health Geogr 2006; 5: 22.
40. Thiblin I, Kristiansson M, Rajs J: Anabolicandrogenic steroids and behavioural patterns among violent offenders. J Forensic Psychiatry 1997; 8: 299-310.